152 related articles for article (PubMed ID: 3500074)
1. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
[TBL] [Abstract][Full Text] [Related]
2. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
[TBL] [Abstract][Full Text] [Related]
3. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of calcitonin gene-related peptide in patients with medullary thyroid carcinoma.
Kim S; Morimoto S; Kawai Y; Koh E; Onishi T; Ogihara T
J Clin Chem Clin Biochem; 1989 Jul; 27(7):423-7. PubMed ID: 2794874
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
Takami H; Ito K
Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of plasma calcitonin gene-related peptide (CGRP) level in patients with thyroid disease].
Takami H; Shikata J; Ozaki O; Mimura T; Ito K
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):401-6. PubMed ID: 2359396
[TBL] [Abstract][Full Text] [Related]
7. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay for calcitonin gene-related peptide and its measurement in sera of patients with thyroid disease.
Yoshida H; Hamada N; Noh J; Ito K; Morii H
Endocrinol Jpn; 1992 Feb; 39(1):81-91. PubMed ID: 1376685
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier.
Morimoto S; Nishimura J; Miyauchi A; Takai S; Okada Y; Onishi T; Fukuo K; Lee S; Kumahara Y
J Clin Endocrinol Metab; 1982 Sep; 55(3):594-6. PubMed ID: 7096542
[TBL] [Abstract][Full Text] [Related]
10. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.
Gharib H; Kao PC; Heath H
Mayo Clin Proc; 1987 May; 62(5):373-8. PubMed ID: 3573825
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinoma.
Schifter S; Williams ED; Craig RK; Hansen HH
Clin Endocrinol (Oxf); 1986 Dec; 25(6):703-10. PubMed ID: 3308183
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay of urinary calcitonin in normal subjects and in patients with medullary carcinoma of the thyroid.
Morimoto S; Onishi T; Okada Y; Lee S; Imanaka S; Fukuo K; Kono H; Kumahara Y
Endocrinol Jpn; 1982 Feb; 29(1):1-10. PubMed ID: 7106058
[TBL] [Abstract][Full Text] [Related]
14. Expression of calcitonin gene-related peptide in medullary thyroid cancer.
Pacini F; Fugazzola L; Basolo F; Elisei R; Pinchera A
J Endocrinol Invest; 1992; 15(7):539-42. PubMed ID: 1447491
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening.
Schifter S
Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082
[TBL] [Abstract][Full Text] [Related]
16. Concomitant production of immunoreactive gastrin-releasing peptide and calcitonin in medullary carcinoma of the thyroid.
Yamaguchi K; Abe K; Adachi I; Suzuki M; Kimura S; Kameya T; Yanaihara N
Metabolism; 1984 Aug; 33(8):724-7. PubMed ID: 6748945
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide: possible tumor marker for medullary thyroid cancer.
Poston GJ; Seitz PK; Townsend CM; Alexander RW; Rajaraman S; Cooper CW; Thompson JC
Surgery; 1987 Dec; 102(6):1049-54. PubMed ID: 3500524
[TBL] [Abstract][Full Text] [Related]
18. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
[TBL] [Abstract][Full Text] [Related]
19. Role of cytosolic free calcium concentration in the secretion of calcitonin gene-related peptide and calcitonin from medullary thyroid carcinoma cells.
Haller-Brem S; Muff R; Petermann JB; Born W; Roos BA; Fischer JA
Endocrinology; 1987 Oct; 121(4):1272-7. PubMed ID: 3498624
[TBL] [Abstract][Full Text] [Related]
20. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
